Certara Services Archives

Blog

Advancing pharmacoequity through model-informed drug development: Insights from ASCPT 2026

Explore how model-informed drug development and AI are advancing pharmacoequity and shaping the future of…

Certara2026 年 3 月 11 日

Press Coverage Video

Advancing Bayesian Methods in Clinical Trials

Explore how Bayesian statistical methods are reshaping clinical trial design. Learn how FDA support, adaptive…

Certara2026 年 3 月 9 日

Blog

Pharmacovigilance Aggregate Reporting in China

Learn best practices for China pharmacovigilance aggregate reporting, with expert support and regulatory guidance insights.

Certara2026 年 3 月 6 日

Blog

DIA RSIDM 2026: From Doing Digital to Being Data-Driven

JTVCdGVhbV9qdW1wX2xpc3QlNUQ= 2026 年 3 月 5 日 The atmosphere at this year's DIA RSIDM conference was defined by…

Certara2026 年 3 月 5 日

Publication

Model-Based Meta-Analysis of Objective Response Rate and Survival Endpoints to Compare PD-1 and PD-L1 Treatment Outcomes in Non-Small Cell Lung Cancer

This study used model-based meta-analysis (MBMA) to assess how well objective response rate (ORR) predicts…

Danielle Pillsbury2026 年 3 月 4 日

Conference

Apotekarsocieteten 临床药理学策略在药物开发中的应用

Danielle Pillsbury2026 年 3 月 2 日

Fact Sheet

文件质量和管理

Ensure submission readiness with Certara’s Document Quality services. We deliver compliant, inspection-ready regulatory documents that…

Certara2026 年 2 月 27 日

Fact Sheet

安全性与药物警戒撰写

Expertly delivering Safety & Pharmacovigilance Writing services, including Aggregate Safety Reports, Risk Management Plans, and…

Certara2026 年 2 月 27 日

博客

Rare Disease Day 2026: Accelerating Rare Disease Drug Development Through Cross-Functional Innovation

On Rare Disease Day 2026, Certara experts share how cross-functional innovation, regulatory strategies for rare…

Certara2026 年 2 月 26 日

Press Release

Certara Reports Fourth Quarter 2025 Financial Results; Provides Full Year 2026 Guidance

FY 2025 Revenue of $418.8M (9% growth) and Adj. EBITDA of $134.5M (10% growth) Fourth…

Certara2026 年 2 月 26 日

Certara 服务

Advancing pharmacoequity through model-informed drug development: Insights from ASCPT 2026

Advancing Bayesian Methods in Clinical Trials

Pharmacovigilance Aggregate Reporting in China

DIA RSIDM 2026: From Doing Digital to Being Data-Driven

Model-Based Meta-Analysis of Objective Response Rate and Survival Endpoints to Compare PD-1 and PD-L1 Treatment Outcomes in Non-Small Cell Lung Cancer

Apotekarsocieteten 临床药理学策略在药物开发中的应用

文件质量和管理

安全性与药物警戒撰写

Rare Disease Day 2026: Accelerating Rare Disease Drug Development Through Cross-Functional Innovation

Certara Reports Fourth Quarter 2025 Financial Results; Provides Full Year 2026 Guidance

订阅时事通讯

快捷链接

解决方案

联系我们